Scientific Planning Committee
Carol C. Cheung MD, PhD, JD, FRCPC
Carol Cheung is Deputy Director of Canadian Biomarker Quality Assurance.
For any questions about the Webinar series content, feel free to reach out to me at carol.cheung@cbqa.ca
Shamini Selvarajah PhD, FACMG, FCCMG
Assistant Professor, Department of Laboratory Medicine & Pathobiology, University of Toronto
Clinical Molecular Geneticist, Division of Clinical Laboratory Genetics, University Health Network
Tracy Stockley PhD, FCCMG, FACMG
Scheme Director, Canadian Biomarker Quality Assurance
Professor, Department of Laboratory Medicine & Pathobiology
University Health Network, Toronto
Dr. Stockley is a molecular geneticist and former Head of the Division of Clinical Laboratory Genetics at the University Health Network in Toronto. The Division is the largest genetic pathology laboratory service in Canada, encompassing three laboratories: the clinical Genome Diagnostics Laboratory and Cancer Cytogenetics Laboratory at Toronto General Hospital, as well as the Advanced Molecular Diagnostics Laboratory at the Princess Margaret Cancer Centre.
At UHN, Dr. Stockley participates in overseeing genetic testing for oncology, including companion diagnostics and the development of genomic tests for emerging biomarkers. She is dedicated to improving quality assurance in high-complexity laboratory testing, and engages in quality activities with several national and international organizations, such as Health Canada, the Canadian Biomarker Quality Assurance program, the College of American Pathologists, the Association for Molecular Pathology, the European Molecular Quality Network and the International Organization for Standardization (ISO). Additionally, Dr. Stockley is a Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto and has served as a President of the Canadian College of Medical Geneticists. Dr. Stockley is also a cancer survivor with a personal commitment to patient support and engagement in research.
Episode 1
Leonard Angka PhD
Canadian Cholangiocarcinoma Collaborative (C3),
Ottawa
Pinaki Bose PhD
OncoHelix Inc.
University of Calgary, Calgary
Tracy Stockley PhD, FCCMG, FACMG
Scheme Director, Canadian Biomarker Quality Assurance
Professor, Department of Laboratory Medicine & Pathobiology
University Health Network, Toronto
Dr. Stockley is a molecular geneticist and former Head of the Division of Clinical Laboratory Genetics at the University Health Network in Toronto. The Division is the largest genetic pathology laboratory service in Canada, encompassing three laboratories: the clinical Genome Diagnostics Laboratory and Cancer Cytogenetics Laboratory at Toronto General Hospital, as well as the Advanced Molecular Diagnostics Laboratory at the Princess Margaret Cancer Centre.
At UHN, Dr. Stockley participates in overseeing genetic testing for oncology, including companion diagnostics and the development of genomic tests for emerging biomarkers. She is dedicated to improving quality assurance in high-complexity laboratory testing, and engages in quality activities with several national and international organizations, such as Health Canada, the Canadian Biomarker Quality Assurance program, the College of American Pathologists, the Association for Molecular Pathology, the European Molecular Quality Network and the International Organization for Standardization (ISO). Additionally, Dr. Stockley is a Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto and has served as a President of the Canadian College of Medical Geneticists. Dr. Stockley is also a cancer survivor with a personal commitment to patient support and engagement in research.
Episode 2
Alan Spatz
Director, Department of Pathology, Jewish General Hospital
Professor, Departments of Pathology, and Oncology, McGill University
Tracy Stockley PhD, FCCMG, FACMG
Scheme Director, Canadian Biomarker Quality Assurance
Professor, Department of Laboratory Medicine & Pathobiology
University Health Network, Toronto
Dr. Stockley is a molecular geneticist and former Head of the Division of Clinical Laboratory Genetics at the University Health Network in Toronto. The Division is the largest genetic pathology laboratory service in Canada, encompassing three laboratories: the clinical Genome Diagnostics Laboratory and Cancer Cytogenetics Laboratory at Toronto General Hospital, as well as the Advanced Molecular Diagnostics Laboratory at the Princess Margaret Cancer Centre.
At UHN, Dr. Stockley participates in overseeing genetic testing for oncology, including companion diagnostics and the development of genomic tests for emerging biomarkers. She is dedicated to improving quality assurance in high-complexity laboratory testing, and engages in quality activities with several national and international organizations, such as Health Canada, the Canadian Biomarker Quality Assurance program, the College of American Pathologists, the Association for Molecular Pathology, the European Molecular Quality Network and the International Organization for Standardization (ISO). Additionally, Dr. Stockley is a Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto and has served as a President of the Canadian College of Medical Geneticists. Dr. Stockley is also a cancer survivor with a personal commitment to patient support and engagement in research.
Tracy Tucker PhD, FCCMG
Vancouver, British Columbia
Clinical Professor, University of British Columbia
Clinical Molecular Geneticist & Cytogeneticist, Cancer Genetics Laboratory, BC Cancer Agency
Dr. Tracy Tucker is a CCMG certified Cytogeneticist and Molecular Geneticist at the Cancer Genetic and Genomics Laboratory (CGL) at the BC Cancer Centre and is a Clinical Professor in the Department of Pathology and Laboratory Medicine at the University of British Columbia (UBC). She received her PhD in Medical Genetics at UBC followed by clinical genetics fellowship training and Canadian College of Medical Geneticists (CCMG) certification at BC Children’s and Women’s Hospitals. In her clinical role, Dr. Tucker is focused on the identification of acquired and inherited genetic changes to diagnose cancer patients and help direct their care. She has a keen interest in transitioning high throughput technologist into the clinical laboratory for routine cancer care. Dr. Tucker has educational leadership roles, both locally and nationally, to enhance genetics training for pathology residents, undergraduate students, CCMG fellows and practicing pathologists. She is a recipient of a UBC Killam Teaching Award.
Faculty Disclosure
Speakers and/or planning committee members will disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships within the last two (2) years with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic.
This intent is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of facts.
It remains for the audience to determine whether the speaker’s outside interests may reflect a possible bias in either the exposition or the conclusions presented.